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ABSTRACT
Objectives Changes in air temperature are associated
with an increase in cardiovascular events, but the role of
procoagulant and proinflammatory blood markers is still
poorly understood. The authors investigated the
association between air temperature and fibrinogen,
plasminogen activator inhibitor type 1, interleukin-6 and
high-sensitivity C reactive protein in two potentially
susceptible groups.
Methods This prospective panel study was conducted
between March 2007 and December 2008 in Augsburg,
Germany. The study population comprised 187
participants with type 2 diabetes mellitus or impaired
glucose tolerance and 87 participants with genetic
polymorphisms on the detoxification and inflammation
pathways. Overall, 1766 repeated blood measurements
were collected. Hourly meteorology data were available
from a central measurement site. The association
between temperature and blood markers was analysed
with additive mixed models.
Results For type 2 diabetes mellitus and impaired
glucose tolerance participants, the authors observed
immediate, lagged and cumulative increases in fibrinogen
(range of percentage changes in geometric mean:
0.6%e0.8%) and plasminogen activator inhibitor type 1
(6.0%e10.1%) in association with a 58C temperature
decrement. Participants with a body mass index above
30 kg/m2 as well as females showed particularly strong
fibrinogen effects. In participants with the special genetic
background, 58C decreases in the 5-day average of
temperature led to a change of 8.0% (95% CI 0.5% to
16.2%) in interleukin-6 and of 8.4% (95% CI 15.8%
to 0.3%) in high-sensitivity C reactive protein, the latter
driven by physically active individuals.
Conclusions The authors observed different
temperature effects on blood markers in two potentially
susceptible groups probably indicating varying underlying
biological mechanisms. This study results might provide
a link between temperature and cardiovascular events.
INTRODUCTION
Increases as well as decreases in air temperature
have been shown to be associated with higher
morbidity1 2 and mortality3e5 due to cardiovascular
disease (CVD). Various procoagulant and proin-
flammatory blood markers are predictors for acute
or chronic CVD.6e9 Especially fibrinogen and C
reactive protein (CRP) seem to be predictors that
are independent of traditional risk factors such as
increased waist circumference, low physical
activity, smoking and diabetes.6
Some blood markers show a seasonal variation.
While many studies10e12 observed higher fibrinogen
levels in winter, a study of Rudez et al13 observed
higher levels in summer. It has also been shown
that CRP levels are higher in winter and spring.14
Furthermore, Kanikowska et al15 detected signifi-
cantly higher blood levels of interleukin-6 (IL-6) in
winter and summer compared with spring and
autumn.
What this paper adds
< This paper contributes to the understanding of
associations between air temperature and
cardiovascular events, for which no clear link
has been established yet, by looking at
intermediate markers associated with CVD in
relation to changes in temperature.
< Only few studies have examined associations
between temperature and C reactive protein,
fibrinogen and IL-6, whereas so far no study
investigated temperature effects on plasminogen
activator inhibitor 1.
< Potentially susceptible individuals, in particular
subjects with type 2 diabetes or IGT and those
with a genetic predisposition on the detoxifica-
tion or inflammation pathways, were selected
for this study.
< We observed significant changes in blood
markers in association with temperature
decreases which differed between the two
groups and which were modified by sex, BMI
and physical activity.
< Our study might help to identify susceptible
individuals which should take precautions in
special weather conditions and might help to
explain the differences in susceptibility to air
temperature seen in other studies.
< Additional materials are
published online only. To view
this file please visit the journal
online (http://dx.doi.org/
10.1136/oemed-2011-100469).
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Physiological mechanisms explaining the potential association
between temperature changes and cardiovascular events are still
poorly understood. Previous studies investigating the tempera-
ture effect of controlled exposure to cold water or cold air showed
elevated levels of risk factors for CVDdamong them, an increase
of plasminogen activator inhibitor type 1 (PAI-1),16 fibrinogen,17
red blood cells, blood viscosity18 and blood pressure.19 In a Euro-
pean study with repeated measurements of fibrinogen, IL-6 and
CRP in myocardial infarction (MI) survivors, temperature
decreases 3 days before bloodwithdrawalwere associatedwith an
increase in fibrinogen.20 Moreover, elevated levels of IL-6 and CRP
in association with decreases in the 5-day average of temperature
were detected in the same study. A study from the Boston area in
elderly men showed temperature effects only for CRP but not for
IL-6.21 CRP increased due to temperature decreases up to 1 day
before blood withdrawal and decreases in the 4-week average of
temperature.21 Furthermore, Hampel et al22 found decreases in
CRP and fibrinogen in association with a 108C temperature
decrease in patients with coronary heart disease (CHD).
Elderly and individuals with diabetes2 23 24 are assumed to be
more susceptible to temperature changes than others. Accord-
ingly, Wolf et al2 observed an association between temperature
drops and MI only in individuals above 55 years of age, whereas
younger subjects did not react to temperature decreases.
Schwartz23 detected a higher risk of mortality on hot days in
individuals with diabetes compared with other individuals.
In this study, we investigated immediate, lagged and cumu-
lative effects of ambient air temperature on repeatedly measured
blood markers of coagulation and inflammation in a moderate
climate. We assessed the blood markers fibrinogen, PAI-1, IL-6
and high-sensitivity C reactive protein (hsCRP) in a group of
individuals with type 2 diabetes mellitus (T2D) or impaired
glucose tolerance (IGT), a prediabetic state, and in individuals
with genetic polymorphisms on the detoxification and inflam-
mation pathways but without T2D or IGT. Our hypothesis was
to observe increases in blood markers in association with
temperature drops in participants with T2D or IGTas well as in
participants with the specific genetic background.
MATERIALS AND METHODS
Study design and study population
A prospective panel studywas conducted between 19March 2007
and 17 December 2008 in Augsburg, Germany, as part of the
University of Rochester Particulate Matter Center investigations.
Individuals with T2D or IGT and healthy individuals with
a special genetic background were recruited from the KORA
(Cooperative Health Research in the Region of Augsburg) F4
cohort that was conducted between 2006 and 2008.25 26 The
participants were living in Augsburg or in the two adjacent
counties. T2D was diagnosed either by a physician or a typical
medication use (ATC-Code A10). Remaining participants had an
oral glucose tolerance test (OGTT). Participants with a fasting
glucose level >125 mg/dl or a 2 h OGTT glucose level $200 mg/
dl were also specified as having T2D. IGT was specified as 2 h
OGTT glucose levels $140 mg/dl but <200 mg/dl. The special
genetic backgroundwas defined as having the null polymorphism
for GSTM1 and either two major alleles of the single-nucleotide
polymorphism (SNP) rs1205 located in the CRP gene or at least
one minor allele of the SNP rs1800790 located in the fibrinogen
gene FGB. GSTM1 is assumed to be involved in the protection
against oxidative stress and hence in inflammatory processes.27
The two latter SNPs have been shown to have an influence on
CRP and fibrinogen levels, respectively.28e30 The individuals were
invited to up to seven examinations scheduled every 4e6 weeks
on the same day of the week and the same time of the day. At the
first examination, data on health status, medication use as well as
disease and smoking history were collected. For a subgroup of the
participants also an electrocardiogram was recorded. Therefore,
diseases or participant characteristics with a potential influence
on blood markers or cardiac function led to exclusion of partici-
pants or single examinations. In detail, exclusion criteria were
current smoking or being an ex-smoker for<12 months; intake of
platelet aggregation inhibitors except for acetylsalicylic acid
(ASA); a MI and/or interventional procedure (percutaneous
transluminal coronary angioplasty, bypass surgery) <6 months
before the start of the study and chronic inflammatory diseases
such as Crohn’s disease, colitis ulcerosa and rheumatoid arthritis.
Single blood samples of the participants were excluded if the
participant had a cold/influenza or a surgery or dental surgeon
intervention or an acute infection of the urological/gastro-intes-
tinal/respiratory tract during the 3 days prior the examination.
Furthermore, if a participant was not in the study area before the
blood withdrawal, the respective blood sample was excluded
from analyses. All methods used in the study were conducted
according to Standard Operating Procedures. The study protocol
was accredited by the Ethics Commission of the Bavarian
Chamber of Physicians (Bayerische Landesaerztekammer) and all
participants gave written informed consent.
Clinical measurements
At each visit, a venous blood withdrawal was conducted. For the
analysis of blood markers, ethylenediaminetetraacetic acid and
citrate samples were drawn (Becton Dickinson, Franklin Lakes,
New Jersey, USA) at each visit. Samples were centrifuged at 48C
and aliquots were immediately stored at 808C until shipment
on dry ice to the collaborating laboratories. We investigated the
coagulation markers fibrinogen and PAI-1 as well as the inflam-
matory markers IL-6 and hsCRP. Fibrinogen was analysed by
immunoephelometry (Dade Behring, Marburg, Germany). PAI-1
was determined by a home-made assay using the mesoscale
platform, and determination of IL-6 was accomplished using an
IL-6 Ultrasensitive Kit (Meso Scale diagnostics, Gaithersburg,
Maryland, USA). HsCRP was analysed by a Meso Scale
Discovery Kit (Meso Scale diagnostics). Only individuals with at
least two valid blood samples were considered for the analysis.
Meteorology and air pollution data
Hourly means of air temperature, relative humidity, barometric
pressure and air pollutants such as ultrafine particles (UFP;
particle number count, with a size range of 0.01e0.1 mm in
aerodynamic diameter), PM2.5 (particulate matter (mass) with
a size range of <2.5 mm in aerodynamic diameter) and PM10
(particulate matter (mass) with a size range of <10 mm in
aerodynamic diameter) were measured at a central measurement
site in Augsburg throughout the study period.31 32 Ozone was
measured as hourly means at a monitoring site operated by the
Bavarian Environment Agency (LfU). Missing values of meteo-
rology and air pollution data were not replaced since <1% of
24 h averages were missing (meteorological variables, ozone,
PM2.5, PM10) or no parallel measurement with other devices
(UFP) was available. For each participant and visit, we calculated
individual 24 h averages of each meteorological variable
preceding the blood withdrawal (lag 0: 0e23 h) for up to 4 days
(lag 1: 24e47 h, lag 2: 48e71 h, lag 3: 72e95 h, lag 4: 96e119 h)
if more than two-thirds of the hourly measurement were
available. In addition, we calculated the mean of these 5 days (5-
day average). For a more detailed description of the meteoro-
logical and air pollution data, see supplemental material.
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Statistical analysis
Data analysis was performed separately for two groups
consisting of individuals with T2D or IGTand participants with
a special genetic background, respectively. Medians of patient-
specific Spearman correlation coefficients were calculated
between all blood markers. Patient characteristics were compared
between the two groups using a Student t test for continuous
variables and a c2 test for categorical variables. Fisher ’s exact test
was used if one category contained less than five observations.
Mixed models with a random participant effect and including
dummy variables for the group effect were calculated in order to
compare the blood markers between the groups. Because the
halflives of the blood markers were shorter than the intervals
between the visits, we assumed a compound symmetry struc-
ture for the covariance matrix. The p value of the group effect
indicates whether the blood markers differ significantly between
the two groups. In order to analyse air temperature effects on
blood markers, we used additive mixed models with a random
participant effect and a compound symmetry covariance struc-
ture. Data on blood markers were log-transformed to obtain
normally distributed residuals. A confounder selection with long-
term time trend, relative humidity, barometric pressure and day
of the week was conducted for each blood marker separately.
Model selection was done by minimising the Akaike’s Informa-
tion criterion. Long-term time trend and relative humidity with
the same lag as the analysed temperature lag were forced into
the model. Barometric pressure and weekday were only included
in case of model fit improvement. Continuous confounders were
included linearly or smoothly as penalised spline (P-spline) to
allow for non-linear exposure-response functions.33 If trend or
meteorological variables such as relative humidity and baro-
metric pressure were included as a P-spline, we checked whether
a polynomial led to a better model fit. Observations with obvi-
ously extremely large residuals in the confounder model were
excluded from further analysis. After assessing the confounder
models, single temperature lags were included either linearly or
as a P-spline to the confounder model. All analyses were
performed using SAS V.9.2 (SAS Institute Inc.).
Effect modification and sensitivity analysis
Season (winter: October to March vs summer: April to
September), gender (female vs male), body mass index (BMI)
(<30 kg/m2 vs $30 kg/m2), age (<60 vs $60 years), physical
activity (not active vs $1 h/week), intake of statins (yes vs no)
and intake of ASA (yes vs no) were considered as potential
temperature effect modifiers by including a binary interaction
term in the model. In participants with T2D or IGT, we addi-
tionally calculated an interaction analysis with a variable indi-
cating whether the participant also had the specific genetic
background.
Moreover, we studied the robustness of the temperature
effects by performing several sensitivity analyses. We addition-
ally adjusted our models for UFP, PM2.5, PM10 or ozone with the
same lag as temperature. Furthermore, we excluded blood
marker measurements below the 5th or above the 95th percen-
tile to avoid overestimation of effects induced by extreme blood
marker values.
RESULTS
Study population and clinical measurements
Overall, 276 participants were examined and 1799 blood samples
were drawn. One participant with seven blood withdrawals was
excluded because of Loefgren syndrome. One participant was
excluded because only one valid blood sample was available.
Twenty-three blood samples were excluded from analysis
because of an acute disease or surgery within 3 days before the
clinical examination. One participant had MI between his fifth
and sixth visits; therefore, the sixth blood sample was excluded.
One blood sample was not used for analysis because the
participant spent the whole morning before the blood draw
outside the study area. Therefore, temperature measurements
from the central monitoring site in Augsburg preceding the
examination cannot be assigned to this visit. Finally, 1766 valid
blood samples of 274 participants were available for analysis.
Two hundred and twenty-two participants (80.7%) completed
all seven visits. The study population comprised 187 (68%)
participants with T2D or IGTwith 1197 blood samples and 87
(32%) participants with the specific genetic background with
569 blood samples. Clinical characteristics of the participants are
described in table 1. Participants with T2D or IGTwere signifi-
cantly older, more overweight and hypertensive, less physically
active and took more statins and acetylsalicylic acid than those
with the special genetic background. Six hundred and seventy-
nine (57%) and 273 (48%) examinations were performed in
summer in participants with T2D or IGT and a genetic predis-
position, respectively. Fibrinogen, PAI-1, IL-6 and hsCRP were
higher in participants with T2D or IGT. According to the
medians of the patient-specific correlation coefficients, the blood
markers showed only a low correlation (│r│<0.4) (table 2). For
both study groups, all blood markers were slightly higher in
winter compared with summer except for IL-6 in participants
with the special genetic background (data not shown).
Meteorological data
During the study period (645 days), 24 h averages were 10.98C
(SD 7.3) for temperature, 77% (SD 12.6) for relative humidity
and 961.3 hPa (SD 7.6) for barometric pressure. Meteorological
variables were only weakly correlated (│r│<0.5), whereas UFP
with PM2.5/PM10 showed a moderate (r<0.6) and PM2.5 and
PM10 showed a strong correlation (r¼0.93). Ozone was nega-
tively correlated with meteorological variables and other air
pollutants (r¼0.55 to 0.36) (see supplemental table 1).
Association of air temperature and blood markers
In a first step, we added temperature as a P-spline to the models
in order to allow for a non-linear temperatureeresponse rela-
tionship. There was no evidence in either group for a deviation
from linearity for the relationship between temperature and
blood markers (supplemental figure 1). Therefore, temperature
lags were included linearly in the final models. The selected
confounder models for each blood marker are summarised in
supplemental table 2. Linear temperature effects on the blood
markers are presented as per cent change from the geometric
outcome mean per 58C decrease in temperature together with
95% CIs (figure 1). We observed immediate, lagged and cumu-
lative increases in fibrinogen and PAI-1 in association with a drop
in temperature in participants with T2D or IGT. A decrease in
the 5-day average of temperature led to the strongest increase in
fibrinogen (0.8% (95% CI 0.3% to 1.3%)) and PAI-1 (10.1% (95%
CI 6.4% to 13.8%)), respectively. Participants with the genetic
predisposition showed no temperature effects in both blood
markers. We observed effects of a temperature decrease on IL-6
with a lag of one (6.2% (95% CI 0.4% to 12.4%)) up to 4 days
(5.9% (95% CI 0.3% to 11.9%)) as well as for the 5-day average
(8.0% (95% CI 0.5% to 16.2%)) only in participants with the
special genetic background. In the same panel, hsCRP decreased
for lag 0 (9.5% (95% CI 16.6% to 1.8%)), lag 1 (8.0% (95%
CI 15.0% to 0.4%)), lag 2 (7.7% (95% CI 14.5% to
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0.4%)), lag 3 (6.5% (95% CI 13.1% to 0.6%)) and for the 5-
day average (8.4% (95% CI 15.8% to 0.3%)) in association
with a temperature decrement, whereas we found no tempera-
ture effects on hsCRP in participants with T2D or IGT.
Effect modifications
Selected temperature effect modifications in participants with
T2D or IGT are shown in figure 2. Female participants showed
an increase in fibrinogen of about 1% in all lags in association
with temperature decreases, while we observed no temperature
effects in men. Furthermore, we observed an increase in fibrin-
ogen of about 1% in all lags only in participants with a BMI
$30 kg/m2. Participants taking statins tended to show slightly
stronger temperature effects on PAI-1 and hsCRP (figure 2). We
observed a stronger decrease in hsCRP during winter compared
with summer in association with a temperature drop in partic-
ipants with the genetic predisposition (figure 3). In the same
panel, the decrease in hsCRP seemed to be more pronounced in
physically activity individuals, whereas individuals without
physical activity tended to slightly elevated fibrinogen levels in
association with temperature decreases (figure 3). No further
temperature effect modifications on any blood marker were
detected neither in participants with metabolic disorders nor
in those with the special genetic background. Forty-six
participants with T2D or IGT also had the specific genetic
background. However, temperature effects were similar in
participants with and without the genetic predisposition (data
not shown).
Table 2 Medians of the patient-specific Spearman





hsCRP 0.39 0.07 0.18
hsCRP, high-sensitivity C reactive protein; IL-6, interleukin 6; PAI-1,
plasminogen activator inhibitor type 1.
Table 1 Description of clinical characteristics and levels of blood markers in study participants
All (N[274) T2D or IGT (N[187) Special genetic background (N[87) p Value
Age (years), mean (SD) 63.1 (10.9) 66.4 (8.5) 55.9 (12.1) <0.01*
BMI (kg/m2), mean (SD) 29.3 (5.5) 30.5 (5.4) 26.8 (5.0) <0.01*
Age (years), N (%)
<60 98 (36) 45 (24) 53 (61) <0.01y
$60 176 (64) 142 (76) 34 (39)
BMI (kg/m2)z, N (%)
<30 167 (61) 99 (53) 68 (78) <0.01y
$30 106 (39) 87 (47) 19 (22)
Gender, N (%)
Male 157 (57) 108 (58) 49 (56) 0.82y
Female 117 (43) 79 (42) 38 (44)
Smoking, N (%)
Never-smoker 132 (48) 89 (48) 43 (49) 0.24x
Ex-smoker 133 (49) 94 (50) 39 (45)
Occasional smoker 9 (3) 4 (2) 5 (6)
HbA1c (%), N (%)
<6.5 235 (86) 148 (79) 87 (100) <0.01x
$6.5 39 (14) 39 (21) 0 (0)
Physical activity, N (%)
$1 h/week 182 (66) 112 (60) 70 (80) <0.01y
No physical activity 92 (34) 75 (40) 17 (20)
History of N (%)
Type 2 diabetes mellitus 83 (30) 83 (44) 0 (0) <0.01x
Hypertension 169 (62) 135 (72) 34 (39) <0.01y
COPD/emphysema 28 (10) 20 (11) 8 (9) 0.70y
Peripheral artherosclerosis{ 14 (6) 12 (7) 2 (4) 0.44y
Regular medication use, N (%)
Statins 67 (24) 54 (29) 13 (15) 0.01y
Antidiabetic medications 52 (19) 50 (27) 2 (2) <0.01y
Acetylsalicylic acid 65 (23) 43 (23) 12 (14) <0.01y
N GM AM (SD) N GM AM (SD) N GM AM (SD)
Fibrinogen (g/l) 1764 3.5 3.6 (0.6) 1195 3.6 3.7 (0.7) 569 3.3 3.3 (0.5) <0.01**
PAI-1 (ng/ml) 1765 3.5 4.3 (3.5) 1197 3.8 4.7 (3.7) 568 2.9 3.6 (3.1) 0.02**
IL-6 (pg/ml) 1761 1.0 1.4 (3.1) 1193 1.2 1.7 (3.7) 568 0.7 1.0 (0.9) 0.05**
hsCRP (ng/ml) 1765 1.0 2.1 (4.8) 1196 1.2 2.5 (5.6) 569 0.8 1.4 (2.3) <0.01**
*Student’s t test.
yc2 test.
zOne participant without BMI measurement.
xFisher’s exact test.
{Forty-nine participants without data.
**p Value of fixed group effect in mixed effects model.
AM, arithmetic mean; BMI, body mass index; COPD, chronic obstructive pulmonary disease; GM, geometric mean; HbA1c, glycosylated haemoglobin; hsCRP, high-sensitivity C reactive protein;
IGT, impaired glucose tolerance; IL-6, interleukin-6; PAI-1, plasminogen activator inhibitor type 1; T2D, type 2 diabetes mellitus.
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Sensitivity analyses
Adjusting the models for UFP, PM2.5 and PM10 did not change
temperature effects on fibrinogen, PAI-1, IL-6 and hsCRP.
However, temperature effects on IL-6 with a lag of 1 and 4 days
became non-significant when adjusting for ozone in participants
with the special genetic background (supplemental table 1).
Excluding blood samples with values below the 5th and above
the 95th percentile led to non-significant temperature effects




In this study, we investigated short-term temperature effects in
two potentially susceptible groups. Only participants with T2D
or IGT showed immediate, lagged and cumulative increases in
fibrinogen and PAI-1 levels in association with a decrease of 58C
in air temperature. In this group, temperature effects on fibrin-
ogen were stronger in women and in obese participants. We did
not find temperature effects on IL-6 and hsCRP in this group.
However, a drop of 58C in temperature led to elevated IL-6 levels
and a decrease in hsCRP in participants with a special genetic
background. This association was more pronounced in physi-
cally active individuals.
Air temperature and blood markers
Levels of blood markers seem to increase mostly during the
winter.10 14 15 Hence, changes in blood markers due to temper-
ature changes might precede cardiovascular events. However,
knowledge about the effects of temperature on blood markers is
still limited. We observed inverse temperature effects on fibrin-
ogen and PAI-1 only in individuals with T2D or IGT. In accor-
dance to our results, Schneider et al20 and Hampel et al22 found
elevated fibrinogen levels in association with temperature
decrements in MI survivors and in participants with pulmonary
disease. A decrease of 108C in the 5-day average of temperature
led to a 5.5% (95% CI 1.3% to 9.7%) increase in fibrinogen in
pulmonary disease participants,22 which is stronger compared
with our observed 1.6% (95% CI 0.5% to 2.7%) increase in
fibrinogen for the same temperature decline. Schneider et al20
detected the strongest increase of fibrinogen of about 1.3% (95%
CI 0.2% to 2.4%) for lag 3, which is very similar compared with
our observed increase of 1.2% (95% CI 0.2% to 2.2%) for
a temperature decrement of 108C. In our participants with T2D
or IGT, a decrease in temperature led to elevated levels of PAI-1
that is among others synthesised in adipocytes and has
a prothrombotic function.34 In our study, participants with T2D
or IGT were more overweight and showed higher PAI-1 levels
than those with the special genetic background. Adipose tissue
Figure 1 Air temperature effects on fibrinogen, plasminogen activator inhibitor type 1 (PAI-1), interleukin-6 (IL-6) and high-sensitivity C reactive
protein (hsCRP).
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and T2D are both associated with metabolic disorders and a low-
grade systemic chronic inflammation, which increases the risk of
CVD.34 We speculate that an additional increase in PAI-1 due to
a temperature decrease might partly explain the increased dia-
betes-related mortality in cold months.35 Our findings suggest
a stimulation of the IL-6 production in association with
a decrease in temperature in participants with the special genetic
background. Elevated blood levels of IL-6 induce the production
of acute-phase proteins such as hsCRP in the liver. In contrast to
our initial hypothesis and other studies,20 21 we found decreases
in hsCRP and no change in fibrinogen in association with
a temperature decrease for participants with the potential
genetic predisposition. However, a previous study by Hampel et
al22 also detected a short-term decrease in CRP associated with
a drop in temperature. We can only speculate that our findings
are a consequence of the special genetic background specified by
the null polymorphism of GSTM1 and either two major alleles
of the SNP rs1205 located in the CRP gene or at least one minor
allele of the SNP rs1800790 located in the fibrinogen gene FGB.
Studies found higher28 and lower30 hsCRP levels in individuals
with at least one minor allele of the rs1205. Having at least one
minor allele of the rs1800790 seems to be associated with higher
fibrinogen levels.29 Tang et al36 reported higher hsCRP and
fibrinogen levels in patients with the null polymorphism of
GSTM1 compared with patients with the wild type of GSTM1.
However, elevated levels of fibrinogen and hsCRP are also
common in individuals with T2D.37 38 In line with these find-
ings, participants with T2D or IGT in our data had higher
fibrinogen and hsCRP levels than those with the special genetic
background. We therefore assume that a metabolic disorder like
T2D or IGT might have stronger influence on levels of blood
markers of fibrinogen or hsCRP and on temperature sensitivity
than the defined genetic background.
Potential mechanisms
The physiological mechanisms leading from temperature
changes to cardiovascular events are still not clearly established.
Exposure to cold can have various effects like an increase of
Figure 2 Air temperature effects on fibrinogen, plasminogen activator inhibitor type 1 (PAI-1), interleukin 6 (IL-6) and high-sensitivity C reactive
protein (CRP) in participants with type 2 diabetes mellitus (TD2) or impaired glucose tolerance (IGT) modified by gender, body mass index (BMI) and
intake of statins.
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blood pressure and heart rate18 19 39 as well as changes in blood
markers. Elderly individuals seem to be more susceptible to cold
temperature compared with younger individuals because they
showed a higher increase of blood pressure after superficial skin
cooling19 and higher longitudinal changes in blood pressure
regarding seasonal temperature changes.39 There is also evidence
for stronger temperature effects in individuals with T2D.
Accordingly, Schwartz23 reported a higher mortality risk on hot
days in individuals with diabetes than in those without diabetes.
Since procoagulatory and proinflammatory blood markers are
predictors for CVD,7e9 temperature effects on blood markers in
subjects with diabetes are also of interest as this maybe one
possible biological pathway linking temperature changes and
mortality in individuals with T2D. Accordingly, Hampel et al22
observed stronger changes in blood markers of coagulation in
association with temperature decreases in participants with
a CHD and T2D than in those with a CHD but without T2D.
Earlier studies suggested that controlled exposure to cold air or
water led to an increase in blood markers like fibrinogen16 and
PAI-1.17 Furthermore, it has been shown that a short-term
decrease in temperature was associated with increased levels of
fibrinogen, IL-6 and CRP.20 Fibrinogen,6 IL-67 and CRP6e8 are
established predictors of cardiovascular risk and IL-6 and CRP
seem to be more associated with fatal than non-fatal cardio-
vascular events.9 Several blood markers like fibrinogen, IL-6 and
CRP showed seasonal variations with increases mostly in the
cold season10e12 14 15 and might therefore be one possible link to
the peak of cardiovascular events in winter. However, in our
study, temperature effects were inconsistent between partici-
pants with T2D or IGT and participants with a special genetic
background. Participants with T2D or IGT were older, more
often overweight, more strongly medicated whereupon partici-
pants with T2D took more statins and antidiabetic medications
compared with participants with IGT and had a worse overall
health than those with the special genetic background. A
combination of these factors might have influenced the
susceptibility to temperature.
Air temperature effect modifications
In participants with T2D or IGT, we found increases in fibrin-
ogen in association with a temperature decrement in women
only possibly indicating a gender dimorphism in thermoregula-
tion. In accordance with our findings, cold-related cardiovascular
symptoms like chest pain or arrhythmia seem to be more
common in women than men.40 Furthermore, Schwartz23
observed a higher risk of mortality on very cold days in women
than men in a case-only study. However, Wolf et al2 detected
similar risks for MI in association with temperature decreases in
both women and men. With regard to body weight, we found
temperature effects on fibrinogen only in obese participants
with T2D or IGT. Obesity is supposed to be an inflammatory
state,41 and this might influence temperature sensitivity.
Nevertheless, Hampel et al22 and Schneider et al20 observed no
temperature effect modification on fibrinogen by BMI.
Regarding PAI-1 and hsCRP, participants with statin intake
showed a higher susceptibility to a temperature decrease
compared with participants without statin intake. The intake of
statins might indicate a poorer overall health, possibly leading to
a stronger susceptibility to temperature changes. The tempera-
ture-related decrease in hsCRP was only observed in physically
active participants with the special genetic background. Since it
has been shown that physical activity may reduce inflamma-
tion,42 we can only speculate that physical activity led to
decreases in CRP in association with drops in temperature.
Figure 3 Air temperature effects on fibrinogen and high-sensitivity C
reactive protein (CRP) in participants with special genetic background
modified by season and physical activity.
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Strengths and limitations
One strength of panel studies is the ability to analyse intra-
individual variations due to the repeated measurement design. In
our study, each participant had up to seven blood withdrawals
within a time period of about 11 months. Moreover, each
participant serves as his or her own control. Therefore, time-
invariant confounders are accounted for by design, and no
control group is needed. We excluded blood samples of partici-
pants with acute infection or surgery during the 3 days before
the blood withdrawal to exclude the possibility that the
observed temperature effects result from an infectious disease.
Air pollutants have also been associated with levels of blood
markers,43 44 but it is still unclear whether air pollutants are
confounders or effect modifiers of the temperatureeblood
marker response. However, adjustment for air pollutants hardly
changed our results for all blood markers. Therefore, we are
confident that the observed temperature effects on blood
markers are not confounded by air pollutants. Further strengths
are the non-linear confounder adjustment and the information
on patient characteristics allowing us to perform subgroup
analysis. We only measured outdoor temperature while partici-
pants usually spend a lot of time indoors, especially during the
cold season. We additionally have to consider a misclassification
of personal exposure because we measured the meteorological
variables at central measurement sites, even if there is a possible
variation of these variables over the study area. However, several
studies showed an increase of cardiovascular events in winter, so
it is very likely that even a short-term exposure to low outdoor
temperatures may influence blood markers. We used a variety of
outcome and interaction variables in our analysis; thus, some
associations may have occurred by chance. Also, we only looked
at a small selection of blood markers that have not or only hardly
been studied in association with air temperature. For these
reasons, the results can be regarded as first evidence but need to
be interpreted with care. In addition, our study population
consisted of participants who were either healthy with a special
genetic background or who had T2D or IGT. Hence, our results
cannot be generalised for the whole population. However, in
industrialised countries, T2D is a widespread disease with
a growing number of incident cases, and we therefore consider it
important to do research on this particularly susceptible popu-
lation. The limited geographical study area and the restriction to
a moderate climate further reduce the generalisability of our
results. The detected temperature effects on blood markers are
small and might be considered clinically irrelevant. Still, even
small changes may indicate a disrupted haemostasis and many
acute little changes may have additive effects and lead to
a progression of atherosclerosis progression and chronic disease.
Moreover, small but consistent associations can give ideas for
possible underlying pathways linking temperature and CVD.
CONCLUSIONS
Our study showed an association between temperature and
blood markers of coagulation and inflammation in participants
with T2D or IGT and in participants with the special genetic
background. The observed differences in temperature effects on
blood markers between the two study groups potentially indi-
cate different underlying biologic mechanisms. Our results
might partly explain the observed seasonal variation of blood
markers and adverse cardiac events.
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44. Rückerl R, Greven S, Ljungman P, et al. Air pollution and inflammation (interleukin-6,




678 Occup Environ Med 2012;69:670–678. doi:10.1136/oemed-2011-100469
 group.bmj.com on September 24, 2014 - Published by oem.bmj.comDownloaded from 
doi: 10.1136/oemed-2011-100469
25, 2012
 2012 69: 670-678 originally published online JulyOccup Environ Med
 
Claudia Luise Schäuble, Regina Hampel, Susanne Breitner, et al.
 
individuals
inflammation in potentially susceptible
blood markers of coagulation and 
Short-term effects of air temperature on
 http://oem.bmj.com/content/69/9/670.full.html







This article cites 43 articles, 11 of which can be accessed free at:
service
Email alerting
the box at the top right corner of the online article.
Receive free email alerts when new articles cite this article. Sign up in
Notes
 http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
 http://journals.bmj.com/cgi/reprintform
To order reprints go to:
 http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
 group.bmj.com on September 24, 2014 - Published by oem.bmj.comDownloaded from 
